Alaunos Therapeutics Inc (TCRT)

[WalkingHome]

"2. Results may be observable on a per patient basis quickly - weeks."

A Phase II Study Using Autologous T-Cells Engineered Using the Sleeping Beauty Transposon/Transposase System to Express T-Cell Receptors Reactive Against Mutated Neoantigens in Patients With Metastatic Cancer - http://ClinicalTrials.gov. Starts in 5 days
A Phase II Study Using the Administration of Autologous T-Cells Engineered Using the Sleeping...
A Phase II Study Using the Administration of Autologous T-Cells Engineered Using the Sleeping Beauty Transposon/Transposase System to Express T-Cell Receptors Reactive Against Mutated Neoantigens in...
clinicaltrials.gov
9:44 AM · Sep 25, 2019·Twitter for iPhone
6
Retweets
20
Likes
ThomasUBarton
@ThomasUBarton1
·
7h
Replying to
@ThomasUBarton1
2. Results may be observable on a per patient basis quickly - weeks.
https://twitter.com/ThomasUBarton1/status/1176854964448006150